Biweekly paclitaxel plus gemcitabine is a highly active and well tolerated regimen in women with advanced breast cancer

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1427, 2004-01, pp. : 14-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Carboplatin plus gemcitabine followed by paclitaxel is a well tolerated sequential regimen

By  

Inpharma, Vol. 1, Iss. 1305, 2001-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Docetaxel plus cisplatin: active and well tolerated in locally advanced or metastatic gastric cancer

By  

Inpharma, Vol. 1, Iss. 1278, 2001-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

High-dose chemotherapy regimen well tolerated in breast cancer

By  

Inpharma, Vol. 1, Iss. 1320, 2002-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Pegylated liposomal doxorubicin is active and well tolerated in elderly women with metastatic breast cancer

By  

Inpharma, Vol. 1, Iss. 1649, 2008-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

A regimen of trastuzumab, paclitaxel, carboplatin and gemcitabine has favourable efficacy in advanced, HER2-positive urothelial cancer

By  

Inpharma, Vol. 1, Iss. 1591, 2007-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite